InsidersTradesSigma
申报总数
公司
▲ 买入（10 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
10
已披露卖出
1
T+90 胜率
100%
T+90 平均收益
+23.5%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the detailed record of transactions filed by Lu Hongbo, Director. Officer active across 3 companies, notably Arrowhead Pharmaceuticals, INC.. Aggregated, 13 disclosures have been recorded. Breakdown: 10 buys · 1 sell. Total volume traded: €16.3m. History available since 12 August 2022. The latest transaction was disclosed on 12 May 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Lu Hongbo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
13 条申报中的 13 条
About Lu Hongbo
Lu Hongbo is a director at Arrowhead Pharmaceuticals, INC., Terns Pharmaceuticals, Inc. and Zenas BioPharma, Inc. He has 9 filings in total, and across the 9 sampled filings from 2022-08-16 to 2026-05-14, buys amount to EUR 13325186 and sells to EUR 389135. The modal transaction nature is Acquisition.
